KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Opko Health (OPK) over the last 10 years, with Q1 2025 value amounting to $51.7 million.

  • Opko Health's Change in Acquisitions & Divestments changed N/A to $51.7 million in Q1 2025 from the same period last year, while for Sep 2025 it was $171.5 million, marking a year-over-year increase of 26705.4%. This contributed to the annual value of $166.6 million for FY2024, which is 4567032.97% up from last year.
  • Opko Health's Change in Acquisitions & Divestments amounted to $51.7 million in Q1 2025.
  • In the past 5 years, Opko Health's Change in Acquisitions & Divestments registered a high of $119.9 million during Q4 2024, and its lowest value of -$478000.0 during Q3 2023.
  • Over the past 5 years, Opko Health's median Change in Acquisitions & Divestments value was $27.4 million (recorded in 2021), while the average stood at $42.8 million.
  • Examining YoY changes over the last 5 years, Opko Health's Change in Acquisitions & Divestments showed a top increase of 987635.98% in 2024 and a maximum decrease of 987635.98% in 2024.
  • Quarter analysis of 5 years shows Opko Health's Change in Acquisitions & Divestments stood at $8.1 million in 2021, then soared by 1328.68% to $115.4 million in 2022, then plummeted by 100.41% to -$478000.0 in 2023, then skyrocketed by 25178.03% to $119.9 million in 2024, then tumbled by 56.91% to $51.7 million in 2025.
  • Its last three reported values are $51.7 million in Q1 2025, $119.9 million for Q4 2024, and $46.7 million during Q3 2024.